Impressions on 5-fluorouracil in Bangladesh. Prolonged worthwhile survival in gastrointestinal malignancies.
The controversies on 5-fluorouracil (5-FU) appear to be gradually culminating in two divergent groups of workers. One group uses low doses of the drug administered weeklyand the other group prefers high doses, the so-called standard loading dose system or its modification. The present study reports impressions with a modified repeated protracted high dose schedule of 5-FU in 325 patients with far-advanced solid malignancies treated in Bangladesh with 20% objective and 40% subjective responses. The morbidityrate was high but the protraction and the vigilance perhaps have kept the mortality rateat 1.5%. About 14% of 120 patients with gastrointestinal metastatic cancers have survived more than 1 year and 8% beyong 2 years. Review of the literature of 5-FU reveal atendency towards better response rates with higher drug concentrations particularly in the tumor-bearing area. It is noted that some prolonged survivors are always recorded byworkers using high dose schedules but not yet by those using weekly schedules. It is imperative to wait for both short- and long-term results of the controlled trials before valid conclusions can be made.
D001459:Bangladesh; D004341:Drug Evaluation; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy*; D006801:Humans; D007890:Leiomyosarcoma / Q000188:drug therapy; D008297:Male; D009362:Neoplasm Metastasis; D011655:Pulmonary Embolism / Q000139:chemically induced; D013274:Stomach Neoplasms / Q000188:drug therapy; D013997:Time Factors
D005472:Fluorouracil